Estrella Immunopharma, Inc. (ESLA)

Estrella Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023
Period Ending	Mar 20, 2026	Sep 30, 2025	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023
Market Cap	39	43	43	38	39	41
Market Cap Growth	9.66%	-0.01%	13.99%	-2.48%	-3.87%	178.23%
Enterprise Value	37.89	41.8	39.27	33.94	39.07	43.17
Last Close Price	1.04	1.15	1.20	1.05	1.11	10.84
PE Ratio	-	-2.67	-4.80	-3.89	-4.44	-0.30
PB Ratio	-	-4.42	10.16	8.92	-	-6.03
P/TBV Ratio	-3.85	-4.26	7.60	6.66	-	-0.49
P/FCF Ratio	-	-	-2.70	-2.37	-2.43	-30.42
P/OCF Ratio	-	-	-2.70	-2.37	-2.43	-30.42
EV/EBITDA Ratio	-	-2.64	-5.37	-4.64	-5.35	-3.88
EV/EBIT Ratio	-	-2.64	-5.37	-4.64	-5.35	-3.88
EV/FCF Ratio	-	-	-2.44	-2.11	-2.43	-32.31
Net Debt / Equity Ratio	0.17	0.17	-0.97	-0.97	-	0.37
Net Debt / EBITDA Ratio	0.11	0.10	0.57	0.57	-	0.22
Net Debt / FCF Ratio	-	-	0.26	0.26	-	1.86
Quick Ratio	0.12	0.12	23.05	23.05	-	0.28
Current Ratio	0.15	0.15	24.65	24.65	-	0.28
Return on Equity (ROE)	527.08%	569.02%	-342.19%	-342.19%	-206.82%	-6772.72%
Return on Assets (ROA)	-367.54%	-396.78%	-328.31%	-328.31%	-150.39%	-174.31%
Return on Invested Capital (ROIC)	273.59%	295.36%	-5135.34%	-5135.34%	4605.22%	243.65%
Return on Capital Employed (ROCE)	527.02%	568.99%	-342.11%	-342.11%	-169.01%	-1157.20%
Earnings Yield	-33.26%	-37.39%	-20.83%	-25.71%	-22.52%	-335.33%
FCF Yield	-	0.00%	-37.00%	-42.17%	-41.12%	-3.29%
Buyback Yield / Dilution	-	0.00%	-22.21%	-27.22%	-24.69%	0.00%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q